Cabot Corporation(CBT)Earnings, Financials & Key Ratios

CBT•NYSE

$82.41

$4.3B mkt cap·13.7× P/E·Price updated May 6, 2026

SectorBasic Materials IndustrySpecialty Chemicals Sub-IndustryCarbon and activated carbon materials

AboutCabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers reinforcing carbons used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty carbons used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.Show more

Revenue$3.71B-7.0%
EBITDA$775M+1.3%
Net Income$331M-12.9%
EPS (Diluted)6.02-10.4%
Gross Margin25.32%+5.3%
EBITDA Margin20.87%+9.0%
Operating Margin16.73%+8.8%
Net Margin8.91%-6.3%
ROE20.09%-20.8%
ROIC17.38%-1.4%
Debt/Equity0.71-14.8%
Interest Coverage8.42+11.8%

Technical→

CBT Key Insights

Cabot Corporation (CBT) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Excellent 3Y average ROE of 27.3%
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 2.1%
✓Share count reduced 2.7% through buybacks
✓Trading near 52-week high

✗Weaknesses

No significant weaknesses identified

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

CBT Price & Volume

Cabot Corporation (CBT) stock price & volume — 10-year historical chart

Loading chart...

CBT Growth Metrics

Cabot Corporation (CBT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years2.6%

5 Years7.27%

3 Years-4.93%

TTM-8.52%

Profit CAGR

10 Years-

5 Years-

3 Years16.56%

TTM-34.18%

EPS CAGR

10 Years-

5 Years-

3 Years18.48%

TTM-31.05%

Return on Capital

10 Years14.28%

5 Years20.1%

3 Years20.98%

Last Year21.33%

CBT Recent Earnings

Cabot Corporation (CBT) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 3/12 qtrs (25%)

Q2 2026Latest

May 5, 2026

EPS

$1.61

Est $1.47

+9.5%

Revenue

$904M

Est $900M

+0.4%

Q1 2026

Feb 3, 2026

EPS

$1.53

Est $1.40

+9.3%

Revenue

$849M

Est $887M

-4.3%

Q4 2025

Nov 3, 2025

EPS

$1.70

Est $1.68

+1.2%

Revenue

$899M

Est $930M

-3.3%

Q3 2025

Aug 4, 2025

EPS

$1.90

Est $1.82

+4.4%

Revenue

$923M

Est $978M

-5.6%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 5, 2026	$1.61vs $1.47+9.5%	$904Mvs $900M+0.4%
Q1 2026	Feb 3, 2026	$1.53vs $1.40+9.3%	$849Mvs $887M-4.3%
Q4 2025	Nov 3, 2025	$1.70vs $1.68+1.2%	$899Mvs $930M-3.3%
Q3 2025	Aug 4, 2025	$1.90vs $1.82+4.4%	$923Mvs $978M-5.6%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
KROKronos Worldwide, Inc.Direct Competitor	870.95M	7.57	-7.89	-1.47%	-7.12%	-17%	0.77
IOSPInnospec Inc.Direct Competitor	1.92B	77.67	16.63	-3.65%	6.56%	8.23%	0.06
HWKNHawkins, Inc.Direct Competitor	3.47B	167.11	41.47	6.01%	7.75%	15.88%	0.35
TROXTronox Holdings plcDirect Competitor	1.62B	10.13	-3.41	-5.73%	-16.22%	-29.25%	2.48
ASIXAdvanSix Inc.Direct Competitor	834.75M	25.16	13.98	0.31%	3.24%	6.05%	0.47
ECVTEcovyst Inc.Direct Competitor	1.62B	14.68	-24.07	2.7%	-7.71%	-10.2%	0.71
PPGPPG Industries, Inc.Product Competitor	24.96B	111.53	16.12	0.19%	9.83%	31.06%
EMNEastman Chemical CompanyProduct Competitor	8.66B	75.74	18.47	-6.71%	4.62%	6.69%	0.84

Compare CBT vs Peers

Cabot Corporation (CBT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs KRO

Most directly comparable listed peer for CBT.

Scale Benchmark

vs MPC

Larger-name benchmark to compare CBT against a more recognizable public peer.

Peer Set

Compare Top 5

vs KRO, IOSP, HWKN, TROX

CBT Income Statement

Cabot Corporation (CBT) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Sep'17	Sep'18	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	Sep'25	TTM
Sales/Revenue	2.72B	3.24B	3.34B	2.61B	3.41B	4.32B	3.93B	3.99B	3.71B	3.58B
Revenue Growth %	12.69%	19.32%	2.93%	-21.67%	30.41%	26.75%	-9.03%	1.6%	-7.04%	-8.52%
Cost of Goods Sold	2.06B	2.46B	2.65B	2.11B	2.61B	3.44B	3.09B	3.03B	2.77B	2.69B
COGS % of Revenue	76%	75.91%	79.47%	80.87%	76.56%	79.52%	78.66%	75.96%	74.68%	-
Gross Profit	652M▲ 0%	781M▲ 19.8%	685M▼ 12.3%	500M▼ 27.0%	799M▲ 59.8%	885M▲ 10.8%	839M▼ 5.2%	960M▲ 14.4%	940M▼ 2.1%	885M▲ 0%
Gross Margin %	24%	24.09%	20.53%	19.13%	23.44%	20.48%	21.34%	24.04%	25.32%	24.76%
Gross Profit Growth %	12.8%	19.79%	-12.29%	-27.01%	59.8%	10.76%	-5.2%	14.42%	-2.08%	-
Operating Expenses	319M	628M	379M	479M	345M	496M	313M	346M	319M	309M
OpEx % of Revenue	11.74%	19.37%	11.36%	18.32%	10.12%	11.48%	7.96%	8.66%	8.59%	-
Selling, General & Admin	260M	305M	290M	292M	289M	258M	253M	283M	260M	266M
SG&A % of Revenue	9.57%	9.41%	8.69%	11.17%	8.48%	5.97%	6.44%	7.09%	7%	-
Research & Development	56M	66M	60M	57M	56M	55M	57M	63M	59M	57M
R&D % of Revenue	2.06%	2.04%	1.8%	2.18%	1.64%	1.27%	1.45%	1.58%	1.59%	-
Other Operating Expenses	0	254M	29M	130M	0	183M	3M	0	0	-1000K
Operating Income	336M▲ 0%	156M▼ 53.6%	306M▲ 96.2%	21M▼ 93.1%	454M▲ 2061.9%	389M▼ 14.3%	526M▲ 35.2%	614M▲ 16.7%	621M▲ 1.1%	562M▲ 0%
Operating Margin %	12.37%	4.81%	9.17%	0.8%	13.32%	9%	13.38%	15.37%	16.73%	15.72%
Operating Income Growth %	34.4%	-53.57%	96.15%	-93.14%	2061.9%	-14.32%	35.22%	16.73%	1.14%	-
EBITDA	491M	305M	454M	179M	614M	535M	670M	765M	775M	731M
EBITDA Margin %	18.07%	9.41%	13.61%	6.85%	18.01%	12.38%	17.04%	19.15%	20.87%	20.45%
EBITDA Growth %	19.46%	-37.88%	48.85%	-60.57%	243.02%	-12.87%	25.23%	14.18%	1.31%	-7.12%
D&A (Non-Cash Add-back)	155M	149M	148M	158M	160M	146M	144M	151M	154M	169M
EBIT	344M	171M	314M	20M	455M	391M	541M	610M	640M	574M
Net Interest Income	-44M	-44M	-50M	-45M	-41M	-45M	-59M	-49M	-49M	-29M
Interest Income	9M	10M	9M	8M	8M	11M	31M	32M	27M	28M
Interest Expense	53M	54M	59M	53M	49M	56M	90M	81M	76M	39M
Other Income/Expense	-32M	-27M	-50M	-51M	-45M	-44M	-70M	-79M	-49M	-48M
Pretax Income	288M▲ 0%	117M▼ 59.4%	256M▲ 118.8%	-30M▼ 111.7%	409M▲ 1463.3%	345M▼ 15.6%	456M▲ 32.2%	535M▲ 17.3%	572M▲ 6.9%	514M▲ 0%
Pretax Margin %	10.6%	3.61%	7.67%	-1.15%	12%	7.98%	11.6%	13.4%	15.41%	14.38%
Income Tax	29M	193M	70M	191M	123M	102M	-28M	111M	196M	187M
Effective Tax Rate %	10.07%	164.96%	27.34%	-636.67%	30.07%	29.57%	-6.14%	20.75%	34.27%	36.38%
Net Income	241M▲ 0%	-113M▼ 146.9%	157M▲ 238.9%	-238M▼ 251.6%	250M▲ 205.0%	209M▼ 16.4%	445M▲ 112.9%	380M▼ 14.6%	331M▼ 12.9%	285M▲ 0%
Net Margin %	8.87%	-3.49%	4.7%	-9.1%	7.33%	4.84%	11.32%	9.51%	8.91%	7.97%
Net Income Growth %	61.75%	-146.89%	238.94%	-251.59%	205.04%	-16.4%	112.92%	-14.61%	-12.89%	-34.18%
Net Income (Continuing)	273M	-74M	186M	-221M	286M	243M	484M	424M	376M	327M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	121M	125M	136M	123M	143M	134M	143M	165M	155M	119M
EPS (Diluted)	3.81▲ 0%	-1.83▼ 148.0%	2.67▲ 245.9%	-3.96▼ 248.3%	4.34▲ 209.6%	3.62▼ 16.6%	7.73▲ 113.5%	6.72▼ 13.1%	6.02▼ 10.4%	5.46▲ 0%
EPS Growth %	61.44%	-148.03%	245.9%	-248.31%	209.6%	-16.59%	113.54%	-13.07%	-10.42%	-31.05%
EPS (Basic)	3.89	-1.87	2.67	-3.96	4.36	3.65	7.79	6.79	6.07	-
Diluted Shares Outstanding	62.7M	61.7M	58.8M	56.6M	56.8M	56.9M	56.5M	55.7M	54.2M	52.2M
Basic Shares Outstanding	61.88M	60.37M	58.7M	56.53M	56.73M	56.25M	55.24M	54.3M	53.7M	52M
Dividend Payout Ratio	31.95%	-	50.96%	-	32%	40.19%	19.78%	24.47%	29%	-

CBT Balance Sheet

Cabot Corporation (CBT) balance sheet — assets, liabilities & shareholders' equity

Line item	Sep'17	Sep'18	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	Sep'25	TTM
Total Current Assets	1.26B	1.39B	1.21B	978M	1.43B	1.82B	1.63B	1.6B	1.54B	1.55B
Cash & Short-Term Investments	280M	175M	169M	151M	168M	206M	238M	223M	258M	252M
Cash Only	280M	175M	169M	151M	168M	206M	238M	223M	258M	252M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	527M	637M	530M	418M	645M	836M	695M	733M	671M	657M
Days Sales Outstanding	70.8	71.72	57.97	58.37	69.06	70.62	64.53	66.99	65.96	67.21
Inventory	396M	511M	466M	359M	523M	664M	585M	552M	504M	522M
Days Inventory Outstanding	70	75.79	64.14	61.98	73.14	70.54	69.06	66.41	66.34	69.88
Other Current Assets	0	0	0	0	0	0	108M	0	106M	116M
Total Non-Current Assets	2.05B	1.86B	1.79B	1.8B	1.88B	1.71B	1.98B	2.13B	2.28B	2.35B
Property, Plant & Equipment	1.3B	1.3B	1.35B	1.31B	1.38B	1.27B	1.41B	1.53B	1.71B	0
Fixed Asset Turnover	2.08x	2.50x	2.48x	1.99x	2.48x	3.40x	2.78x	2.60x	2.17x	4.23x
Goodwill	154M	93M	90M	134M	140M	129M	134M	133M	134M	136M
Intangible Assets	137M	98M	96M	103M	100M	63M	60M	53M	55M	53M
Long-Term Investments	56M	52M	39M	39M	40M	20M	20M	23M	16M	66M
Other Non-Current Assets	150M	185M	58M	160M	172M	178M	172M	388M	180M	4.6B
Total Assets	3.31B▲ 0%	3.24B▼ 2.1%	3B▼ 7.4%	2.78B▼ 7.4%	3.31B▲ 18.9%	3.52B▲ 6.6%	3.6B▲ 2.2%	3.74B▲ 3.7%	3.81B▲ 2.1%	3.9B▲ 0%
Asset Turnover	0.82x	1.00x	1.11x	0.94x	1.03x	1.23x	1.09x	1.07x	0.97x	0.93x
Asset Growth %	4.88%	-2.05%	-7.4%	-7.42%	18.88%	6.62%	2.24%	3.66%	2.11%	15.44%
Total Current Liabilities	741M	952M	599M	529M	1.15B	1.1B	822M	772M	957M	1.07B
Accounts Payable	339M	446M	390M	316M	480M	533M	438M	495M	459M	598M
Days Payables Outstanding	59.92	66.15	53.68	54.56	67.13	56.62	51.7	59.55	60.42	75.58
Short-Term Debt	263M	284M	40M	21M	445M	354M	182M	67M	274M	436M
Deferred Revenue (Current)	-97M	29M	0	0	0	0	0	0	0	0
Other Current Liabilities	22M	26M	118M	46M	75M	66M	55M	167M	77M	0
Current Ratio	1.70x	1.46x	2.02x	1.85x	1.24x	1.65x	1.98x	2.08x	1.61x	1.61x
Quick Ratio	1.17x	0.92x	1.24x	1.17x	0.79x	1.05x	1.27x	1.36x	1.08x	1.08x
Cash Conversion Cycle	80.87	81.36	68.43	65.79	75.07	84.53	81.88	73.84	71.88	61.51
Total Non-Current Liabilities	970M	1.01B	1.27B	1.44B	1.07B	1.39B	1.38B	1.37B	1.15B	1.26B
Long-Term Debt	661M	719M	1.02B	1.09B	717M	1.09B	1.09B	1.15B	856M	863M
Capital Lease Obligations	0	10M	9M	89M	84M	83M	84M	111M	85M	85M
Deferred Tax Liabilities	38M	42M	41M	58M	73M	65M	50M	42M	39M	162M
Other Non-Current Liabilities	253M	284M	238M	197M	195M	151M	147M	69M	173M	1.06B
Total Liabilities	1.71B	1.97B	1.87B	1.97B	2.22B	2.49B	2.2B	2.15B	2.11B	2.33B
Total Debt	924M	1B	1.06B	1.2B	1.25B	1.53B	1.36B	1.33B	1.22B	436M
Net Debt	644M	828M	895M	1.05B	1.08B	1.32B	1.12B	1.11B	957M	436M
Debt / Equity	0.58x	0.78x	0.94x	1.48x	1.14x	1.48x	0.97x	0.84x	0.71x	0.71x
Debt / EBITDA	1.88x	3.29x	2.34x	6.73x	2.03x	2.85x	2.03x	1.74x	1.57x	0.60x
Net Debt / EBITDA	1.31x	2.71x	1.97x	5.88x	1.76x	2.47x	1.67x	1.45x	1.23x	1.23x
Interest Coverage	6.49x	3.17x	5.32x	0.38x	9.29x	6.98x	6.01x	7.53x	8.42x	14.72x
Total Equity	1.6B▲ 0%	1.28B▼ 20.1%	1.13B▼ 11.3%	814M▼ 28.2%	1.09B▲ 33.9%	1.03B▼ 5.3%	1.41B▲ 36.3%	1.59B▲ 13.0%	1.71B▲ 7.2%	1.69B▲ 0%
Equity Growth %	16.69%	-20.11%	-11.34%	-28.22%	33.91%	-5.32%	36.34%	13.01%	7.23%	39.96%
Book Value per Share	25.53	20.73	19.29	14.38	19.19	18.14	24.90	28.55	31.46	32.32
Total Shareholders' Equity	1.48B	1.15B	998M	691M	947M	898M	1.26B	1.43B	1.55B	1.57B
Common Stock	62M	61M	57M	57M	57M	56M	55M	54M	53M	-3M
Retained Earnings	1.68B	1.42B	1.34B	989M	1.16B	1.28B	1.57B	1.73B	1.83B	1.83B
Treasury Stock	-6M	-7M	-5M	-4M	-4M	-4M	-3M	-3M	-3M	-3M
Accumulated OCI	-259M	-317M	-391M	-351M	-289M	-439M	-362M	-360M	-335M	-316M
Minority Interest	121M	125M	136M	123M	143M	134M	143M	165M	155M	119M

CBT Cash Flow Statement

Cabot Corporation (CBT) cash flow — operating, investing & free cash flow history

Line item	Sep'17	Sep'18	Sep'19	Sep'20	Sep'21	Sep'22	Sep'23	Sep'24	Sep'25	TTM
Cash from Operations	340M	299M	361M	377M	257M	100M	595M	692M	665M	665M
Operating CF Margin %	12.51%	9.22%	10.82%	14.42%	7.54%	2.31%	15.14%	17.33%	17.91%	-
Operating CF Growth %	-11.92%	-12.06%	20.74%	4.43%	-31.83%	-61.09%	495%	16.3%	-3.9%	34.74%
Net Income	266M	-74M	186M	-221M	286M	243M	484M	424M	376M	285M
Depreciation & Amortization	155M	149M	148M	158M	160M	146M	144M	151M	154M	169M
Stock-Based Compensation	16M	22M	11M	9M	21M	23M	20M	25M	24M	7M
Deferred Taxes	-35M	91M	-27M	130M	9M	-40M	-156M	-37M	32M	-14M
Other Non-Cash Items	-11M	240M	25M	139M	25M	176M	3M	59M	30M	76M
Working Capital Changes	-51M	-129M	18M	162M	-244M	-448M	100M	70M	49M	129M
Change in Receivables	-23M	-110M	73M	-59M	7M	-287M	153M	-26M	76M	106M
Change in Inventory	-50M	-105M	27M	114M	-174M	-259M	96M	41M	47M	57M
Change in Payables	91M	122M	-75M	-55M	167M	115M	-152M	42M	-67M	-42M
Cash from Investing	-149M	-246M	-94M	-288M	-186M	-118M	-214M	-235M	-298M	-302M
Capital Expenditures	-147M	-229M	-224M	-200M	-195M	-211M	-244M	-241M	-274M	-212M
CapEx % of Revenue	5.41%	7.06%	6.71%	7.65%	5.72%	4.88%	6.21%	6.03%	7.38%	-
Acquisitions	0	-64M	132M	-92M	-92M	70M	6M	0	0	-93M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-2M	47M	-2M	4M	101M	23M	24M	6M	-24M	3M
Cash from Financing	-125M	-141M	-234M	-132M	-60M	145M	-403M	-415M	-336M	-368M
Debt Issued (Net)	-2M	-165M	61M	15M	36M	298M	-179M	-143M	-23M	-16M
Equity Issued (Net)	-40M	-142M	-194M	-44M	3M	-47M	-94M	-152M	-160M	-125M
Dividends Paid	-77M	-80M	-80M	-80M	-80M	-84M	-88M	-93M	-96M	-97M
Share Repurchases	-61M	-142M	-173M	-44M	-3M	-53M	-98M	-172M	-168M	-180M
Other Financing	-14M	246M	-23M	-23M	-19M	-22M	-42M	-27M	-57M	-130M
Net Change in Cash	80M▲ 0%	-105M▼ 231.3%	-6M▲ 94.3%	-18M▼ 200.0%	19M▲ 205.6%	36M▲ 89.5%	32M▼ 11.1%	-15M▼ 146.9%	35M▲ 333.3%	39M▲ 0%
Free Cash Flow	193M▲ 0%	70M▼ 63.7%	137M▲ 95.7%	177M▲ 29.2%	62M▼ 65.0%	-111M▼ 279.0%	351M▲ 416.2%	451M▲ 28.5%	391M▼ 13.3%	459M▲ 0%
FCF Margin %	7.1%	2.16%	4.11%	6.77%	1.82%	-2.57%	8.93%	11.29%	10.53%	12.84%
FCF Growth %	-29.56%	-63.73%	95.71%	29.2%	-64.97%	-279.03%	416.22%	28.49%	-13.3%	59.38%
FCF per Share	3.08	1.13	2.33	3.13	1.09	-1.95	6.21	8.10	7.21	7.21
FCF Conversion (FCF/Net Income)	1.41x	-2.65x	2.30x	-1.58x	1.03x	0.48x	1.34x	1.82x	2.01x	1.61x
Interest Paid	48M	47M	47M	48M	41M	46M	85M	82M	79M	0
Taxes Paid	69M	84M	99M	71M	93M	129M	140M	136M	165M	0

CBT Key Ratios

Cabot Corporation (CBT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	16.21%	-7.85%	13.01%	-24.44%	26.26%	19.7%	36.49%	25.36%	20.09%	16.75%
Return on Invested Capital (ROIC)	11.6%	5.38%	11.1%	0.81%	16.88%	12.91%	16.16%	17.62%	17.38%	17.38%
Gross Margin	24%	24.09%	20.53%	19.13%	23.44%	20.48%	21.34%	24.04%	25.32%	24.76%
Net Margin	8.87%	-3.49%	4.7%	-9.1%	7.33%	4.84%	11.32%	9.51%	8.91%	7.97%
Debt / Equity	0.58x	0.78x	0.94x	1.48x	1.14x	1.48x	0.97x	0.84x	0.71x	0.71x
Interest Coverage	6.49x	3.17x	5.32x	0.38x	9.29x	6.98x	6.01x	7.53x	8.42x	14.72x
FCF Conversion	1.41x	-2.65x	2.30x	-1.58x	1.03x	0.48x	1.34x	1.82x	2.01x	1.61x
Revenue Growth	12.69%	19.32%	2.93%	-21.67%	30.41%	26.75%	-9.03%	1.6%	-7.04%	-8.52%

CBT SEC Filings & Documents

Cabot Corporation (CBT) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 5, 2026·SEC

Material company update

Mar 17, 2026·SEC

Material company update

Feb 3, 2026·SEC

10-K Annual Reports

FY 2025

Nov 24, 2025·SEC

FY 2024

Nov 20, 2024·SEC

10-Q Quarterly Reports

FY 2026

May 6, 2026·SEC

FY 2026

Feb 4, 2026·SEC

FY 2025

Aug 5, 2025·SEC

CBT Frequently Asked Questions

Cabot Corporation (CBT) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Cabot Corporation (CBT) reported $3.58B in revenue for fiscal year 2025. This represents a 93% increase from $1.86B in 1996.

Cabot Corporation (CBT) saw revenue decline by 7.0% over the past year.

Yes, Cabot Corporation (CBT) is profitable, generating $285.0M in net income for fiscal year 2025 (8.9% net margin).

Dividend & Returns

Yes, Cabot Corporation (CBT) pays a dividend with a yield of 2.15%. This makes it attractive for income-focused investors.

Cabot Corporation (CBT) has a return on equity (ROE) of 20.1%. This is excellent, indicating efficient use of shareholder capital.

Cabot Corporation (CBT) generated $459.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More CBT

Cabot Corporation (CBT) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Cabot Corporation(CBT)Earnings, Financials & Key Ratios

CBT Key Insights

✓Strengths

✗Weaknesses

CBT Price & Volume

CBT Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

CBT Recent Earnings

CBT Peer Comparison

Compare CBT vs Peers

vs KRO

vs MPC

Compare Top 5

CBT Income Statement

CBT Balance Sheet

CBT Cash Flow Statement

CBT Key Ratios

CBT SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

CBT Frequently Asked Questions

Explore More CBT

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation